Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 6 records, 1 pages
Search For: Darbepoetin Alfa
Global Darbepoetin Alfa Supply, Demand and Key Producers, 2024-2030
20 Feb 2024
Pharma & Healthcare
The global Darbepoetin Alfa market size is expected to reach $ 4172.3 million by 2030, rising at a market growth of -2.7% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Darbepoetin Alfa Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Darbepoetin Alfa market size was valued at USD 5046 million in 2023 and is forecast to a readjusted size of USD 4172.3 million by 2030 with a CAGR of -2.7% during review period.
USD3480.00
Add To Cart
Global Darbepoetin Alfa Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Darbepoetin Alfa Injection market size was valued at USD 735.7 million in 2023 and is forecast to a readjusted size of USD 1087.5 million by 2030 with a CAGR of 5.7% during review period.
USD3480.00
Add To Cart
Global Darbepoetin Alfa Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
18 Mar 2023
Pharma & Healthcare
Darbepoetin alfa (INN) is a re-engineered form of erythropoietin containing 5 amino acid changes (N30, T32, V87, N88, T90) resulting in the creation of 2 new sites for N-linked carbohydrate addition. It has a 3-fold longer serum half-life compared to epoetin alpha and epoetin beta. It stimulates erythropoiesis (increases red blood cell levels) by the same mechanism as rHuEpo (binding and activating the Epo receptor) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.
USD3480.00
Add To Cart
Global Darbepoetin Alfa Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
30 Aug 2023
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Darbepoetin Alfa Injection market size was valued at USD 735.7 million in 2022 and is forecast to a readjusted size of USD 1087.5 million by 2029 with a CAGR of 5.7% during review period.
USD3480.00
Add To Cart
Global Darbepoetin Alfa Injection Supply, Demand and Key Producers, 2023-2029
30 Aug 2023
Pharma & Healthcare
The global Darbepoetin Alfa Injection market size is expected to reach $ 1087.5 million by 2029, rising at a market growth of 5.7% CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Darbepoetin Alfa
Total: 6 records, 1 pages
The global Darbepoetin Alfa market size is expected to reach $ 4172.3 million by 2030, rising at a market growth of -2.7% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Darbepoetin Alfa market size was valued at USD 5046 million in 2023 and is forecast to a readjusted size of USD 4172.3 million by 2030 with a CAGR of -2.7% during review period.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global Darbepoetin Alfa Injection market size was valued at USD 735.7 million in 2023 and is forecast to a readjusted size of USD 1087.5 million by 2030 with a CAGR of 5.7% during review period.
USD3480.00
Add To Cart
Darbepoetin alfa (INN) is a re-engineered form of erythropoietin containing 5 amino acid changes (N30, T32, V87, N88, T90) resulting in the creation of 2 new sites for N-linked carbohydrate addition. It has a 3-fold longer serum half-life compared to epoetin alpha and epoetin beta. It stimulates erythropoiesis (increases red blood cell levels) by the same mechanism as rHuEpo (binding and activating the Epo receptor) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global Darbepoetin Alfa Injection market size was valued at USD 735.7 million in 2022 and is forecast to a readjusted size of USD 1087.5 million by 2029 with a CAGR of 5.7% during review period.
USD3480.00
Add To Cart
The global Darbepoetin Alfa Injection market size is expected to reach $ 1087.5 million by 2029, rising at a market growth of 5.7% CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>